Childhood encephalopathy due to thiamine pyrophosphokinase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:293955OMIM:614458G96.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Childhood encephalopathy due to thiamine pyrophosphokinase (TPK1) deficiency is an extremely rare inherited metabolic disorder that affects the brain and nervous system. The condition is caused by problems with the TPK1 enzyme, which is responsible for converting thiamine (vitamin B1) into its active form called thiamine pyrophosphate. This active form of thiamine is essential for energy production in cells, especially in the brain. When the enzyme does not work properly, the brain and other organs cannot produce enough energy, leading to progressive damage. Children with this condition typically develop normally at first but then begin to lose skills they had already learned, a process called developmental regression. Common symptoms include episodes of brain dysfunction (encephalopathy), difficulty walking and coordinating movements (ataxia), muscle stiffness or weakness, seizures, and progressive intellectual disability. Some children may also experience dystonia, which causes involuntary muscle contractions and abnormal postures. Treatment focuses on supplementing with high doses of thiamine (vitamin B1) and sometimes biotin, which may help slow disease progression in some patients if started early. However, the response to treatment varies, and many children still experience significant neurological problems despite supplementation. Early diagnosis and prompt treatment are important to give the best chance of preserving brain function. This condition is also known as TPK1 deficiency or thiamine metabolism dysfunction syndrome 5 (THMD5).

Key symptoms:

Loss of previously learned skills (developmental regression)Episodes of brain dysfunction (encephalopathy)Difficulty walking and poor coordination (ataxia)SeizuresMuscle stiffness and spasticityInvoluntary muscle contractions causing abnormal postures (dystonia)Intellectual disabilityDifficulty speaking or loss of speechMuscle weaknessDifficulty swallowingAbnormal eye movementsPoor growth or failure to thriveFatigue and low energy

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.

View clinical trials →

No actively recruiting trials found for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Childhood encephalopathy due to thiamine pyrophosphokinase deficiency community →

No specialists are currently listed for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Childhood encephalopathy due to thiamine pyrophosphokinase deficiencyForum →

No community posts yet. Be the first to share your experience with Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.

Start the conversation →

Latest news about Childhood encephalopathy due to thiamine pyrophosphokinase deficiency

No recent news articles for Childhood encephalopathy due to thiamine pyrophosphokinase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What dose of thiamine should my child take, and how often should it be adjusted?,What signs should I watch for that would indicate an acute encephalopathy episode?,What should I do if my child develops a fever or becomes sick — is there an emergency protocol?,How often should brain MRI and other monitoring tests be repeated?,Are there any clinical trials or new treatments being studied for TPK1 deficiency?,What therapies (physical, occupational, speech) would benefit my child the most right now?,Should other family members be tested for carrier status or the condition itself?

Common questions about Childhood encephalopathy due to thiamine pyrophosphokinase deficiency

What is Childhood encephalopathy due to thiamine pyrophosphokinase deficiency?

Childhood encephalopathy due to thiamine pyrophosphokinase (TPK1) deficiency is an extremely rare inherited metabolic disorder that affects the brain and nervous system. The condition is caused by problems with the TPK1 enzyme, which is responsible for converting thiamine (vitamin B1) into its active form called thiamine pyrophosphate. This active form of thiamine is essential for energy production in cells, especially in the brain. When the enzyme does not work properly, the brain and other organs cannot produce enough energy, leading to progressive damage. Children with this condition typic

How is Childhood encephalopathy due to thiamine pyrophosphokinase deficiency inherited?

Childhood encephalopathy due to thiamine pyrophosphokinase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Childhood encephalopathy due to thiamine pyrophosphokinase deficiency typically begin?

Typical onset of Childhood encephalopathy due to thiamine pyrophosphokinase deficiency is childhood. Age of onset can vary across affected individuals.